Table 1.
Patient | Age and gender | First visit | Adverse effects | Last visit | ||||
Left eye | Right eye | |||||||
Tumours | Exudation | Tumours | Exudation | Tumours* | Exudation | |||
1 | 36 M | One periph. | – | One periph. | Yes | – | No changes | No |
2 | 33 F | One juxtap. | – | – | – | – | No changes | – |
3 | 50 F | One juxtap. | Yes | – | – | – | No changes | Less exudation |
4 | 20 M | One juxtap. | – | – | – | Hypotension | No changes | – |
5 | 15 M | – | – | One periph. | – | – | No changes | – |
6 | 38 F | One juxtap. | – | – | – | – | Withdrawn† | – |
7 | 22 M | Two periph. | – | Two periph. | – | No changes | – |
The table exclusively includes active tumours in the initial or final visit, which was the principal objective of the treatment.
*'No changes’ indicates no new tumours or growth of previous ones.
†Withdrawn from the clinical trial due to a scheduled surgery.
Juxtap, Juxtapapillary; Periph, peripheral.